Literature DB >> 23754242

QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.

Anthony S Russell1, Luiz Lisboa, Marla F Dos Santos, Deepali Kumar, Atul Humar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23754242     DOI： 10.1007/s10067-013-2298-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  16 in total

1.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors:  J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.

Authors:  Elizabeth Coulson; Vadivelu Saravanan; Jennifer Hamilton; Kin Long So; Kin So Long; Lynn Morgan; Carol Heycock; Martin Rynne; Clive Kelly
Journal:  Ann Rheum Dis       Date:  2011-04-22       Impact factor: 19.103

3.  Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation.

Authors:  M H Wenink; K C M Santegoets; A M Platt; W B van den Berg; P L C M van Riel; P Garside; T R D J Radstake; I B McInnes
Journal:  Ann Rheum Dis       Date:  2011-09-08       Impact factor: 19.103

Review 4.  NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.

Authors:  J L Decker; D G Malone; B Haraoui; S M Wahl; L Schrieber; J H Klippel; A D Steinberg; R L Wilder
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

Review 5.  Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis.

Authors:  Joel M Kremer
Journal:  J Clin Rheumatol       Date:  2005-06       Impact factor: 3.517

6.  Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.

Authors:  Sabine Adler; Anne Krivine; Janine Weix; Flore Rozenberg; Odile Launay; Juerg Huesler; Loïc Guillevin; Peter M Villiger
Journal:  Rheumatology (Oxford)       Date:  2011-12-14       Impact factor: 7.580

7.  Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.

Authors:  Jean-Luc Davignon; Jean-Frédéric Boyer; Bénédicte Jamard; Delphine Nigon; Arnaud Constantin; Alain Cantagrel
Journal:  Arthritis Res Ther       Date:  2010-07-15       Impact factor: 5.156

Review 8.  Costimulation blockade in rheumatic diseases: where we are?

Authors:  Vincent Goëb; Maya H Buch; Edward M Vital; Paul Emery
Journal:  Curr Opin Rheumatol       Date:  2009-05       Impact factor: 5.006

9.  Cell-mediated immunity in rheumatoid arthritis.

Authors:  A A Andrianakos; J T Sharp; D A Person; M D Lidsky; J Duffy
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

10.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.